Month: December 2018

Human Longevity, a La Jolla developer of health and disease-prevention technologies, appears to be in a cash crunch, according to a Friday article in the Wall Street Journal. The company, co-founded by genomics pioneer J. Craig Venter, is raising u… […]

Cancer drug developer Viracta Therapeutics said Tuesday it has raised $10 million as part of a larger financing that is still in progress. The Encinitas company got the money from Chinese drug company Salubris, the lead investor. Salubris and Virac… […]

Diabetes therapy developer ViaCyte has raised $80 million, its largest financing to date, ?the San Diego biomedical company said Wednesday. ViaCyte will use the money to advance its stem cell-derived therapies, said Paul Laikind, president and CEO … […]

San Diego?s ResMed, a seller of equipment and software for sleep apnea and related conditions, says it has agreed to buy Propeller Health for $225 million. Madison, Wis.-based Propeller Health provides devices and software for people with chronic o… […]

Vista?s DJO Global has been sold for $3.15 billion in cash by investors led by the Blackstone Group to Colfax Corp, a diversified technology company in Maryland. Sale of the orthopedic products company, announced Nov. 19, is expected to close in th… […]

For good or ill, perhaps both, humanity?s newfound power to change the genome of our species has been put to use. Chinese scientist Jiankui He genetically engineered human embryos, resulting in the first-ever births of genetically altered babies. T… […]

Jecure Therapeutics, a San Diego company targeting inflammatory liver diseases, said Tuesday it has agreed to be purchased by Genentech. The purchase price wasn?t disclosed. Privately held Jecure was founded in 2015 with financing from Versant Vent… […]

The Salk Institute and former Salk scientist Beverly Emerson said they have settled her lawsuit, the last of three gender discrimination cases filed by female researchers in 2017. "The Salk Institute and Dr. Beverly Emerson announce that they … […]

San Diego agricultural biotech company Cibus said Monday it has filed for an IPO of up to $100 million. It’s the second IPO filing for a local biotech in a week. The company says it uses advanced gene-editing technology to favorably alter plant gen… […]

A major new study on Alzheimer?s disease provides previously unknown evidence of how the brain-robbing illness may originate. Moreover, it proposes that certain HIV drugs called reverse transcriptase inhibitors could immediately be repurposed for A… […]

Challenging the popular but pricey EpiPen, San Diego?s Adamis Pharmaceuticals is readying its own emergency allergy medication for sale. Called Symjepi, the product is a pre-filled syringe of epinephrine, used to counteract life-threatening allergi… […]

Synthorx, a La Jolla biotech developing cancer therapies from partly synthetic life, is seeking $100 million in an initial public offering. The Scripps Research spinoff made the filing with the Securities and Exchange Commission on Tuesday. It seek… […]

Arena Pharmaceuticals will get $800 million cash upfront in a mammoth global drug commercialization deal announced Thursday. The San Diego biomedical company licensed its lung disease drug, ralinepag, to North Carolina?s United Therapeutics Corp. I… […]

Muscular and possessing a killer handshake, Bradley Couch fit right in with the athletic set of bicyclists taking part in Saturday?s Padres Pedal the Cause, an annual fundraiser to support cancer patients and research in San Diego. Surprisingly, Co… […]

Henrietta Lacks? ?immortal cells? contributed enormously to the progression of scientific discovery, but Lacks, a poor, black woman who died from cervical cancer in 1951 months after her cells were harvested, never personally benefited from or consente… […]